BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16449206)

  • 1. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
    Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
    Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
    Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
    Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
    Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
    Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
    McGuffie EM; Pacheco D; Carbone GM; Catapano CV
    Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.
    Faria M; Wood CD; White MR; Hélène C; Giovannangeli C
    J Mol Biol; 2001 Feb; 306(1):15-24. PubMed ID: 11178890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
    Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
    Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of triplex DNA-mediated inhibition of transcription initiation in cells.
    Jain A; Magistri M; Napoli S; Carbone GM; Catapano CV
    Biochimie; 2010 Mar; 92(3):317-20. PubMed ID: 20045441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
    Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
    Taniguchi Y; Sasaki S
    Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR
    Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells.
    Shen C; Buck A; Polat B; Schmid-Kotsas A; Matuschek C; Gross HJ; Bachem M; Reske SN
    Cancer Gene Ther; 2003 May; 10(5):403-10. PubMed ID: 12719710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
    D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
    J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides.
    Hélène C
    Anticancer Drug Des; 1991 Dec; 6(6):569-84. PubMed ID: 1772570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
    Zhang L; Wali A; Ramana CV; Rishi AK
    Cancer Res; 2007 Nov; 67(21):10198-206. PubMed ID: 17974960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
    Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.